Skip to content

A Single-Center, Single-Arm, Exploratory Clinical Study on the Efficacy and Safety of Mid-Infrared Light in the Treatment of Rosacea

A Single-Center, Single-Arm, Exploratory Clinical Study on the Efficacy and Safety of Mid-Infrared Light in the Treatment of Rosacea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121202
Enrollment
Unknown
Registered
2026-03-26
Start date
2026-03-26
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Experimental group:MIMO, irradiate the face, parameters: mid-infrared band 2-11 µm, power 90 mW/cm2, twice a day for a total of 8 times, divided into two groups: 10 minutes of irradiation each time an

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Disease duration > 6 months; 3.Meet the diagnostic criteria for ETR and PPR according to the 2017 Chinese Rosacea Consensus; 4.CEA score >= 2.

Exclusion criteria

Exclusion criteria: 1.CEA score < 2; 2.Hypertrophic rosacea; 3.Current use of isotretinoin; 4.Ocular rosacea; 5.Complicated with other skin diseases that may affect the study results; 6.Sensitivity or contraindication to photoelectric therapy, such as photosensitive diseases, administration of photosensitive drugs, or keloid tendency.

Design outcomes

Primary

MeasureTime frame
Clinical doctor's assessment of erythema;Adverse event;

Secondary

MeasureTime frame
Patient self-assessment;Hamilton Anxiety Scale score;The score of the Rosacea Quality of Life Scale;Overall score by the researchers;Hamilton Depression Scale score;Overall severity score of flushing;

Countries

China

Contacts

Public ContactGe Lan

The First Affiliated Hospital of Army Medical University

43793340@qq.com+86 134 5210 5250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026